Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies.
Where this comes from
- Record sourced from PubMed, PMID 31641230.
- Also identified by DOI 10.1038/s41379-019-0379-5 and PMC identifier 8075874.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.